GlobeNewswire

Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
17/09/2026
BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
10 Barrel Brewing Turns 20 with a Bend Birthday Bash Packed with Beer, Bands and Throwback Fun
17/09/2026
Sept. 19 celebration features live music, throwback beers and throwback prices, food trucks, axe throwing, flash tattoos, giveaways and more BEND, Ore., Sept. 17, 2026 (GLOBE NEWSWIRE) -- 10 Barrel Brewing , the Bend- [...]
MitoRx Therapeutics to present new data on MTRX31, its novel mitochondrial-targeted small molecule, at the 62nd EASD Annual Meeting 2026
17/09/2026
Oral presentation on durable and better quality weight loss induced by MTRX31 in an industry-standard preclinical model of obesity, with new data detailing its differentiated mode of action Structural biology and other [...]
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
17/09/2026
Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026 FDA will determine the resubmission classification and establish the applicable review timeline [...]
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
17/09/2026
Payment of Special Dividend Contingent upon Closing of the Pending Merger Transaction RICHMOND, Va., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) (“Indivior”) today announced that its [...]
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
17/09/2026
U.S. Centers for Disease Control and Prevention (CDC) Reports a Significant Year-Over-Year Increase in Nationwide Rabies Exposures and Rabies Immunoglobulin Utilization KedRAB is One of Only Two FDA-Approved Anti-Rabies [...]
Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026
17/09/2026
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced [...]
Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team
17/09/2026
Latest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures Chief Technology Officer Amandeep Thind to lead continued innovation TORONTO, Sept. 17, 2026 [...]
Two Herbalists Spent Six Years Formulating an Energy Bar. Here's Why It Took That Long.
17/09/2026
ILA launches Chocolate and Peanut adaptogenic energy bars, the first products from a formulation process co-founders Amy Saleh and Eileen Brantley refused to rush ATLANTA, GA , Sept. 17, 2026 (GLOBE NEWSWIRE) -- Most [...]
Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award
17/09/2026
Global GIL Recognition Spotlights Apeloa’s End-to-End "API + Drug Product" Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated Markets SHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH
17/09/2026
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH The 2026 Award, open to early career investigators from around the world, was dedicated to advancing research in [...]
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
17/09/2026
Chief Commercial Officer Bryan Downey Joins Panel Discussion on Reinventing the Launch Playbook for Small and Mid-Size Pharma KANSAS CITY, Kan., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a [...]
Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy [...]
First Insight Corporation Launches The Focal Point Podcast
17/09/2026
Monthly conversations on where AI is changing healthcare, where it falls short, and what responsible innovation looks like PORTLAND, Ore., Sept. 17, 2026 (GLOBE NEWSWIRE) -- First Insight Corporation launched The Focal [...]
Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board
17/09/2026
Appointment supports Aerska's progression of its antibody-oligo conjugate platform and growing pipeline of RNA therapeutics for CNS disease Laura brings decades of leadership in developing complex genetic medicines from [...]
Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development
17/09/2026
Geleen, September 17, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing isupartob sodium for the treatment of sepsis, today announced the successful completion of its Series A financing round. The € [...]
Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding
17/09/2026
Heavy menstrual bleeding is reported in approximately 1 in 3 reproductive-aged women, according to the American College of Obstetricians and Gynecologists, with approximately 23 million seeking care from a healthcare [...]
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
17/09/2026
Yale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
17/09/2026
COPENHAGEN, Denmark, Sept. 17, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced that the first patient has been enrolled in Part 2 of the Phase 1b/2a clinical trial of SNIPR001 (NCT06938867), the Company's lead CRISPR- [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum